Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous microfat + PRP versus total wrist denervation for radiocarpal osteoarthritis
2021-006817-12Phase 2Active
- Sponsor
- Assistance Publique–Hôpitaux de Marseille
- Start
- Feb 2022
- Modality
- Cell Therapies, Adoptive Cell Transfer → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of autologous platelet-rich plasma and autologous microfat in wrist osteoarthritis (2 arms), sponsored by Assistance Publique–Hôpitaux de Marseille. Primary endpoint: Pain intensity on visual analog scale. Started Feb 2022; status: active.
02
Drugs
autologous platelet-rich plasmaautologous microfat
03
Conditions
wrist osteoarthritis
Beyond the preview
Go deeper on 2021-006817-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-006817-12.